Odyssey Health (ODYY) Total Debt Growth (3y) (2017 - 2026)
Odyssey Health (ODYY) Total Debt Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 24.63% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 4.89% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 11.72% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 0.11% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -0.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.01% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -13.48% |
| 10 | Odyssey Health | 1.07 Mn | 771,705.04 | - | -10.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -13.80% |
| Jan 31, 2026 | 23.41% |
| Oct 31, 2025 | 4.06% |
| Jul 31, 2025 | 9.01% |
| Apr 30, 2025 | 34.52% |
| Jan 31, 2025 | 38.84% |
| Oct 31, 2024 | 50.94% |
| Jul 31, 2024 | 21.01% |
| Apr 30, 2024 | 67.66% |
| Jan 31, 2024 | 94.36% |
| Oct 31, 2023 | 154.46% |
| Jul 31, 2023 | 157.20% |
| Apr 30, 2023 | 52.61% |
| Jan 31, 2023 | 59.34% |
| Oct 31, 2022 | 53.48% |
| Jul 31, 2022 | 56.12% |
| Apr 30, 2022 | 30.45% |
| Jan 31, 2022 | 29.14% |
| Oct 31, 2021 | 18.38% |
| Jul 31, 2021 | 42.39% |